Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI
Open access

Targeting Histamine H₃ Receptors to Suppress NGF-Driven Hyperexcitability in Neuropathic Pain

Ajeet Kumar Rakesh Kumar Poonam Kumari Aditi V. Bagade A. Yadav Boda Arun Kumar S. Dogra Deepmala Umrao B. Copits C. Zorumski S. Mennerick Prem N. Yadav
Sep 2026 · bioRxiv · 0 citations · 63 references
Biology

TL;DR

Overall, this work suggests a contributing role of H3R in modality-specific effects on sensory processing through its enrichment in specific neuronal populations in DRG.

DOI Semantic Scholar
Read PDF

Similar papers

Aug 2026

PTP1B in dorsal root ganglion nociceptors drives neuropathic pain via a presynaptic Src/GluN2B signaling pathway.

BACKGROUND Neuropathic pain, a debilitating chronic condition, remains a major clinical challenge due to its complex pathogenesis and limited treatment options. Protein tyrosine phosphatase 1B (PTP1B), a key regulator of tyrosine phosphorylation, has been implicated in various diseases, yet its specific role and mechan...

Xiao-Qin Li, Shu-Jin Wu, Rui-Li Sun et al. · 0 citations
Review Open access Oct 2026

Targeting pain where it CouNts: the role of neurotensin signaling in pain and analgesia

Chronic pain affects more than one-fifth of adults in the United States and represents a major public health burden due to its impact on quality of life, productivity, and healthcare costs. Current pharmacological treatments remain limited in efficacy and are often associated with significant adverse effects, highlight...

Alex D. Chapman, Katherine L. Black, G. Leinninger et al. · 0 citations
Aug 2026

Targeting A3 adenosine receptor signaling to enhance analgesia in nonresponders to spinal cord stimulation in male nerve-injured rats.

ABSTRACT Spinal cord stimulation (SCS) is a clinically approved therapy for neuropathic pain (NP), yet a substantial subset of patients fails to respond or shows minimal efficacy, so-called nonresponders. It remains unclear how to resolve this SCS nonresponsiveness. Using a NP model induced by tibial-sparing nerve inju...

Zhao-Li Luo, Jing Liu, Xiang Cui et al. · 0 citations
Open access Sep 2026

NaV1.7-dependent peripheral sensitization drives chronic pain in Parkinson’s disease

It is demonstrated that dopaminergic neurodegeneration initiated within the brain is sufficient to drive persistent peripheral sensory neuron dysfunction and identify CRMP2-dependent regulation of NaV1.7 as a therapeutic target for Parkinsonian pain.

Tyler S. Nelson, Naomi K. Grabus, Heather N. Allen et al. · 1 citation
Open access Aug 2026

Peripheral Nerve Injury Induces an Interferon-Responsive State Centered on Satellite Glial Cells in the DRG That Sustains Neuropathic Pain Through STAT1 and CXCL10 Signaling

Highlights What are the main findings? SNI induces a distinct STAT1-associated IFN SGC population in the DRG, characterized by increased CXCL10 expression. This SGC inflammatory program is associated with sensory-neuron hyperexcitability and pain hypersensitivity. Local STAT1 inhibition or CXCR3 blockade alleviates pai...

Wen-Chao Hu, Fu-Tai Wang, Zi-Yi Niu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.